Pasar al contenido principal

NANOFANTASMAS DE CELULAS EDUCADAS POR EL TUMOR COMO SISTEMAS DE LIBERACION DE FARMACOS DIRIGIDOS FRENTE A CELULAS MADRE DE CANCER DE MAMA Y DE PANCREAS

RTI2018-101309-B-C22

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE GRANADA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Solid lipid nanoparticles to improve bioaccessibility and permeability of orally administered maslinic acid

  • Aguilera-Garrido, Aixa
  • Arranz, Elena
  • Gálvez-Ruiz, María José
  • Marchal, Juan Antonio
  • Galisteo-González, Francisco
  • Giblin, Linda
Maslinic acid (MA) is a plant-derived, low water-soluble compound with antitumor activity. We have formulated MA in the form of solid lipid nanoparticles (SLNs) with three different shell compositions: Poloxamer 407 (PMA), dicarboxylic acid-Poloxamer 407 (PCMA), and HA-coated PCMA (PCMA-HA). These SLNs improved the solubility of MA up to 7.5 mg/mL, are stable in a wide range of pH, and increase the bioaccessibility of MA after in vitro gastrointestinal (GI) digestion. Gastrointestinal digested SLNs afforded MA delivery across in vitro gut barrier models (21 days old Caco-2 and mucus-producing Caco-2/HT29-MTX co-cultures). The cellular fraction of Caco-2/HT29-MTX co-cultures retained more MA from GI digested PCMA-HA than the Caco-2 monolayers. The concentration of MA reached in the basolateral chamber inhibited growth of pancreatic cancer cells, BxPC3. Finally, confocal microscopy images provided evidence that Nile Red incorporated in MA SLNs was capable of crossing Caco-2 monolayers to be taken up by basolaterally located BxPC3 cells. We have demonstrated that SLNs can be used as nanocarriers of hydrophobic antitumor compounds and that these SLNs are suitable for oral consumption and delivery of the bioactive across the gut barrier., This work has been supported by the Ministerio de Ciencia e Innovación (MCIN/AEI/10.13039/501100011033/FEDER) under Grants [RTI2018-101309-B-C21] and [RTI2018-101309-B-C22]; the European Molecular Biology Organization (EMBO-short term fellowships) under Grant 8475; the Enterprise Ireland (Career-FIT) and the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie Grant Agreement No. 713654 (Project MF2018-0151 Food-BIBS); Science Foundation Ireland (SFI) and the Department of Agriculture, Food and Marine on behalf of the Government of Ireland under Grant Number [16/RC/3835]. This work has also been supported by the European Commission; European Regional Development Funds of the Junta de Andalucía; Spanish Ministry of Science and Innovation., Peer reviewed